LONDON, October 29, 2010 /PRNewswire-FirstCall/ -- Hikma Pharmaceuticals,
the multinational pharmaceutical group, announces that it has signed an
agreement to acquire Baxter Healthcare Corporation's US generic injectables
business for a cash consideration of $112 million.
There will be a li